Your account is not claimed yet. You can sign up with ORCID to claim your account.

Ondrej Slanar (O Slanař, Ondřej Slanař)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Venues

Pharmaceutics

Antibiotics (Basel, Switzerland)

Journal of neural transmission (Vienna, Austria : 1996)

Leukemia

This page only lists publications with an associated author ORCID identifier.

Publications

Eliška Dvořáčková, Martin Sima, Andrea Zajacová, Kristýna Vyskočilová, Tereza Kotowski, Kateřina Dunovská, Eva Klapková, Jan Havlín, Robert Lischke, Ondrej Slanar
Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model. Antibiotics (Basel, Switzerland) 12 (9) (2023)
Martin Sima, Ondrej Slanar
Dose Optimization and Targeting Strategies of Anti-Infective Agents. Pharmaceutics 15 (7) (2023)
Jiří Hofmann, Aleš Bartůněk, Tomáš Hauser, Gregor Sedmak, Josef Beránek, Pavel Ryšánek, Martin Sima, Ondrej Slanar
Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans. Leukemia (2023)
Jan Miroslav Hartinger, Danica Michaličková, Eliška Dvořáčková, Karolína Hronová, Elke H J Krekels, Barbora Szonowská, Vladimíra Bednářová, Hana Benáková, Gabriela Kroneislová, Jan Závora, Vladimir Tesar, Ondrej Slanar
Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications. Pharmaceutics 15 (5) (2023)
Irena Murínová, Martin Švidrnoch, Tomáš Gucký, Jan Hlaváč, Pavel Michálek, Ondrej Slanar, Martin Sima
Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections. Antibiotics (Basel, Switzerland) 11 (12) (2022)
Eliška Dvořáčková, Martin Sima, Jakub Petrus, Eva Klapková, Petr Hubáček, Jiří Pozniak, Jan Havlín, Robert Lischke, Ondrej Slanar
Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients. Pharmaceutics 14 (2) (2022)
Martina Kodetova, Radka Hobzova, Jakub Sirc, Jiri Uhlik, Katerina Dunovska, Karel Svojgr, Ana-Irina Cocarta, Andrea Felsoova, Ondrej Slanar, Martin Sima, Igor Kozak, Pavel Pochop
The Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant. Pharmaceutics 14 (5) (2022)
Jana Královičová, Aleš Bartůněk, Jiří Hofmann, Tomáš Křížek, Petr Kozlík, Jaroslava Roušarová, Pavel Ryšánek, Martin Sima, Ondrej Slanar
Pharmacokinetic Variability in Pre-Clinical Studies: Sample Study with Abiraterone in Rats and Implications for Short-Term Comparative Pharmacokinetic Study Designs. Pharmaceutics 14 (3) (2022)
Irena Murínová, Martin Švidrnoch, Tomáš Gucký, Jan Hlaváč, Pavel Michálek, Ondrej Slanar, Martin Sima
Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections. Antibiotics (Basel, Switzerland) 11 (12) (2022)
Martin Sima, Daniel Bobek, Petra Cihlářová, Pavel Ryšánek, Jaroslava Roušarová, Jan Beroušek, Martin Kuchar, Tomáš Vymazal, Ondrej Slanar
Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin. Pharmaceutics 14 (8) (2022)
O Bartošová, C Bonnet, Olga Ulmanová, Martin Sima, F Perlík, Evžen Růžička, Ondrej Slanar
Pupillometry as an indicator of L-DOPA dosages in Parkinson's disease patients. Journal of neural transmission (Vienna, Austria : 1996) 125 (4) (2017)

Ondrej Slanar.css-eqlu8i{font-size:small;padding-left:4px;} (O Slanař, Ondřej Slanař)

Publication Activity (10 Years)

Top Topics

Top Venues

Ondrej Slanar (O Slanař, Ondřej Slanař)